AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $8.05
- 52-wk low
- $1.76
- Prev close
- $5.06
- Mkt cap
- $3.18B
- Beta
- 0.70
- P/S
- 9.8x
Smart money
Earnings
Earnings came in 35.3% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $67.5M | $86.8M | $71.4M | $99.3M |
| Cost of what it sold | $1.4M | -$100.5M | $1.0M | $45.1M |
| Gross profit | $66.0M | $187.3M | $70.4M | $54.2M |
| What it spent | ||||
| Research and development | $75.2M | $68.9M | $62.5M | $63.9M |
| Sales and admin | $34.6M | $36.4M | $38.9M | $39.3M |
| Other operating costs | $51.2M | $155.5M | $50.0M | $2.9M |
| Total operating expenses | $160.9M | $260.8M | $151.5M | $106.1M |
| What was left | ||||
| Operating profit | -$94.9M | -$73.5M | -$81.0M | -$51.9M |
| Profit before tax | -$93.7M | -$71.7M | -$79.7M | -$48.7M |
| Tax | -$2.4M | $184.0K | -$665.0K | -$1.4M |
| Net profit | -$91.3M | -$71.9M | -$79.0M | -$47.3M |
| EBITDA | -$84.7M | -$67.8M | -$71.2M | -$39.2M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
29 articles · 7 days
Coverage is bullish
Tone of tracked coverage
IOVA Maintained by Mizuho -- Price Target Raised to $11.00
Leans bullishAug 18Rice Hall James & Associates LLC Acquires Shares of 1,539,840 Iovance Biotherapeutics, Inc. $IOVA
Leans bullishAug 18Bank of America Corp DE Sells 5,787,694 Shares of Iovance Biotherapeutics, Inc. $IOVA
NeutralAug 16
